Biotech | March 20, 2024
Lonza to buy US biologics site from Roche for US$ 1.2 billion
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
More than 10,000 scientific publications containing EUDRAGIT
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Dalal is an experienced leader at Abbott, having joined in 1995 as a Product Manager
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The Cabinet has approved budgetary support of Rs. 2207.50 crore in the 15th Finance Commission Cycle to run CAPFIMS as a campus of AIIMS, New Delhi.
The investment will catalyse various components of the IndiaAI Mission
Subscribe To Our Newsletter & Stay Updated
